What is the current Point-of-care Testing (POCT) for Inflammatory market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the POCT for Inflammatory market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the POCT for Inflammatory market?

Increasing demand for rapid diagnostic tests and advancements in technology drive the market.

What are the major challenges faced by the POCT for Inflammatory market?

Stringent regulatory requirements and high development costs pose significant challenges.

Which regions are the leaders in the POCT for Inflammatory market?

North America and Europe are the leading regions due to high healthcare expenditure.

Who are the top companies in the POCT for Inflammatory market?

Major players include Roche, Abbott, and Siemens Healthineers.

What are the future opportunities in the POCT for Inflammatory market?

Emerging markets and increasing adoption of decentralized testing offer future opportunities.

How does technology impact the POCT for Inflammatory market future outlook?

Advances in microfluidics and nanotechnology improve test accuracy and convenience.

What is the current regulatory landscape for the POCT for Inflammatory market?

Regulations vary by region, with the FDA and CE marking being key certifications.

How will the POCT for Inflammatory market size evolve in the next 5 years?

The market is expected to reach USD 2.1 billion by 2028, driven by increasing demand.

Point-of-care Testing (POCT) for Inflammatory Expansion Opportunities & Forecast Analysis 2033

Point-of-care Testing (POCT) for Inflammatory by Application (C-Reactive Protein (CRP) Test, Procalcitonin (PCT) Test, Interleukin 6 (IL-6) Test, Serum amyloid A (SAA) Test, Others), by Types (Based on Immunochromatography, Based on Chemiluminescence, Based on Microfluidic Chip), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Point-of-care Testing (POCT) for Inflammatory Market Size | CAGR 10.2 Forecast 2033

Point-of-care Testing (POCT) for Inflammatory Expansion Opportunities & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Point-of-care Testing (POCT) for Inflammatory Market Overview

The Point-of-care Testing (POCT) for Inflammatory market refers to the diagnostic tests performed at or near the site of patient care. As the Point-of-care Testing (POCT) for Inflammatory market size is expected to reach $5.4 billion by 2026, the growth outlook and market forecast suggest a promising industry expansion driven by the increasing demand for rapid and accurate diagnostic tests. The scope of this market encompasses various inflammatory disease tests, including lateral flow assays, molecular diagnostics, and immunoassays.

Loading chart…

The Point-of-care Testing (POCT) for Inflammatory market is expected to grow at a CAGR of 10.3% during the forecast period from 2026 to 2033, driven by macro drivers such as the increasing prevalence of inflammatory diseases, advancements in technology, and the rising demand for rapid diagnostic tests. Key forces shaping the industry include technological shifts towards digital health, regulatory frameworks supporting point-of-care testing, and changing consumer behavior towards self-testing. The largest region in the POCT for Inflammatory market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be driven by the increasing adoption of point-of-care testing in clinical settings and home care.

Report Overview

Report Attribute	Details
Market size value in 2025	8.90 million
Revenue forecast in 2033	19.36 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Abbott; Siemens Healthineers; BioMerieux; Bio-Rad Laboratories; Assure Tech; Guangzhou Wondfo Biotech Co.,Ltd.; Wuhan Easy Diagnosis; Getein Biotech; Beijing Hotgen Biotech Co.,ltd.; Shanghai Upper Bio-Tech Pharma Co.,Ltd.; Qingdao Hightop Biotech Co.,Ltd.; Goldsite Diagnostics Inc.; Genrui Biotech Inc; Hipro Biotechnology CO.,LTD
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Point-of-care Testing (POCT) for Inflammatory market is witnessing significant transformations driven by technological advancements, regulatory support, and shifting consumer preferences. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing demand for rapid and accurate diagnostic testing is driving the growth of the Point-of-care Testing (POCT) for Inflammatory market size, with advancements in technologies such as lateral flow assays and microfluidics enabling the development of portable and user-friendly POCT devices.

Government initiatives and investments in healthcare infrastructure are further fueling the growth forecast of the POCT for Inflammatory market, as these initiatives aim to improve access to diagnostic testing and enhance healthcare outcomes.

Restraints2 items

High development costs and stringent regulatory requirements are restraining the growth of the Point-of-care Testing (POCT) for Inflammatory market, as manufacturers must invest heavily in research and development to ensure compliance with regulatory standards.

Limited reimbursement coverage for POCT devices is also hindering market growth, as healthcare providers and patients may be hesitant to adopt these devices due to cost concerns.

Opportunities2 items

The increasing prevalence of inflammatory diseases, such as rheumatoid arthritis and asthma, is creating opportunities for the Point-of-care Testing (POCT) for Inflammatory market to expand, as POCT devices can enable early diagnosis and monitoring of these conditions.

The growing trend of home healthcare and self-testing is also opening up new avenues for POCT devices, as patients seek convenient and affordable diagnostic testing options.

Challenges2 items

Ensuring the accuracy and reliability of POCT devices is a significant challenge, as these devices must be able to detect biomarkers and provide precise results in diverse clinical settings.

The Point-of-care Testing (POCT) for Inflammatory market is also facing challenges related to data integration and interoperability, as POCT devices must be able to connect with electronic health records and other healthcare systems.

Market Segmentation

Loading chart…

The Point-of-care Testing (POCT) for Inflammatory segmentation can be categorized based on application. This market segmentation insights highlight the various areas where POCT for inflammatory diseases is utilized, contributing to the overall market size. The primary applications of POCT for inflammatory diseases include diagnosis, monitoring, and research. Diagnosis involves the use of POCT devices to identify inflammatory conditions, while monitoring entails tracking the progression of these diseases. Research applications are focused on developing new POCT technologies and understanding the underlying mechanisms of inflammatory diseases.

In terms of types, the POCT for inflammatory market can be segmented into infectious disease testing, autoimmune disease testing, and cancer testing, among others. Infectious disease testing involves the detection of pathogens that cause inflammatory responses, while autoimmune disease testing focuses on identifying conditions where the immune system attacks healthy tissues. Cancer testing, on the other hand, involves the detection of inflammatory biomarkers associated with various types of cancer. Understanding these segments is crucial for market taxonomy and navigating the complex POCT for inflammatory landscape.

Point-of-care Testing (POCT) for Inflammatory Segmentation Breakdown10 items

Application

C-Reactive Protein (CRP) Test

Procalcitonin (PCT) Test

Interleukin 6 (IL-6) Test

Serum amyloid A (SAA) Test

Others

Types

Based on Immunochromatography

Based on Chemiluminescence

Based on Microfluidic Chip

Regional Insights

Loading chart…

The Point-of-care Testing (POCT) for Inflammatory market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be the Asia Pacific, driven by increasing adoption of POCT devices, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - demographics with an aging population, infrastructure with established healthcare systems, and ecosystem maturity with a high level of awareness about POCT devices; Europe - adoption of POCT devices in primary care settings, policies supporting the use of POCT devices, and investments in research and development; Asia Pacific - demographics with a large and growing population, infrastructure with increasing access to healthcare services, and ecosystem maturity with a growing number of POCT device manufacturers; Latin America - adoption of POCT devices in urban areas, policies supporting the use of POCT devices, and investments in healthcare infrastructure; Middle East & Africa - demographics with a growing population, infrastructure with increasing access to healthcare services, and ecosystem maturity with a growing number of POCT device distributors.

The regional forecast indicates that the Asia Pacific region will experience the highest growth rate, driven by increasing adoption of POCT devices and significant investments in healthcare infrastructure. The Point-of-care Testing (POCT) for Inflammatory market is expected to grow significantly in the coming years, driven by increasing demand for POCT devices and increasing awareness about the benefits of POCT devices.

Competitive Landscape

The Point-of-care Testing (POCT) for Inflammatory market is moderately consolidated, driven by a mix of global players and local/regional companies. The competitive landscape is shaped by key levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Point-of-care Testing (POCT) for Inflammatory competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service model, and channel strength.

Companies in this market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies focus on competitive differentiation through technology, service model, channel strength, customization, and cost advantages. Some of the key companies and their strategic focuses are:

Roche: regional expansion

Abbott: premium pricing

Siemens Healthineers: innovation pipeline

BioMerieux: local manufacturing

Bio-Rad Laboratories: OEM tie-ups

Assure Tech: vertical integration

Key Point-of-care Testing (POCT) for Inflammatory Companies15 items

Roche

Abbott

Siemens Healthineers

BioMerieux

Bio-Rad Laboratories

Assure Tech

Guangzhou Wondfo Biotech Co.,Ltd.

Wuhan Easy Diagnosis

Getein Biotech

Beijing Hotgen Biotech Co.,ltd.

Shanghai Upper Bio-Tech Pharma Co.,Ltd.

Qingdao Hightop Biotech Co.,Ltd.

Goldsite Diagnostics Inc.

Genrui Biotech Inc

Hipro Biotechnology CO.,LTD

Market Ecosystem

The Point-of-care Testing (POCT) for Inflammatory ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and channels, to downstream end users. Value is created and captured through the development, manufacturing, and distribution of POCT devices, as well as the provision of related services and support. This ecosystem is characterized by a range of interactions and interdependencies, influencing the adoption and use of POCT for inflammatory conditions.

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and producing POCT devices

Technology providers — developing underlying technologies

System integrators / EPCs — integrating POCT devices into healthcare systems

Distributors / channel partners — delivering POCT devices to end users

Regulators/standards bodies — establishing guidelines and approvals

End users / buyers — utilizing POCT devices for diagnostic purposes

In the Point-of-care Testing (POCT) for Inflammatory ecosystem, control points are largely influenced by regulators and standards bodies, as well as end users who drive demand for specific types of POCT devices. Dependency risks arise from input constraints, such as the availability of critical components, and standards approvals, which can impact the development and commercialization of POCT devices. Furthermore, switching costs and interoperability requirements can also affect the adoption of POCT devices, particularly in regions with diverse healthcare systems and infrastructure. A comprehensive value chain analysis is essential to understanding these complex interactions and identifying opportunities for growth and innovation.

Recent Industry Insights

The Point-of-care Testing (POCT) for Inflammatory industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading diagnostic companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, enabling companies to expand their product portfolios and strengthen their market presence. Furthermore, several product and technology launches have enhanced the accuracy and efficiency of POCT devices, catering to the growing demand for rapid and reliable diagnostic solutions.

Additionally, regulatory changes have supported the adoption of POCT devices, and a shift in consumer and enterprise trends has led to increased investments in digital health technologies. Funding rounds and expansions have also been observed, with companies securing significant investments to develop and commercialize their POCT solutions. These developments are expected to propel the growth of the POCT for Inflammatory market, driving advancements in diagnosis and treatment of inflammatory diseases.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Point-of-care Testing (POCT) for Inflammatory market outlook. The market exhibits high attractiveness due to the increasing prevalence of inflammatory diseases and the need for rapid diagnosis. The competitive intensity is moderate, with key players focusing on innovation and strategic partnerships. The long-term outlook is positive, driven by advancements in technology and growing demand for Point-of-care Testing (POCT) for Inflammatory market outlook.

The innovation landscape is dynamic, with emerging trends such as artificial intelligence and nanotechnology expected to shape the market. The demand-supply balance is favorable, with manufacturers investing in capacity expansion to meet growing demand. However, key risk factors such as regulatory changes and supply chain disruptions need to be carefully managed to ensure sustainable growth.

11 items

1. Executive Summary

2. Point-of-care Testing (POCT) for Inflammatory Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Point-of-care Testing (POCT) for Inflammatory Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Point-of-care Testing (POCT) for Inflammatory Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. C-Reactive Protein (CRP) Test

6.1.2. Procalcitonin (PCT) Test

6.1.3. Interleukin 6 (IL-6) Test

6.1.4. Serum amyloid A (SAA) Test

6.1.5. Others

6.2. Global Point-of-care Testing (POCT) for Inflammatory Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Based on Immunochromatography

6.2.2. Based on Chemiluminescence

6.2.3. Based on Microfluidic Chip

6.3. Global Point-of-care Testing (POCT) for Inflammatory Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Point-of-care Testing (POCT) for Inflammatory Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Point-of-care Testing (POCT) for Inflammatory Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Point-of-care Testing (POCT) for Inflammatory Market Competition by Key Manufacturers

8.1. Global Point-of-care Testing (POCT) for Inflammatory Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Point-of-care Testing (POCT) for Inflammatory: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Roche

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Siemens Healthineers

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BioMerieux

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bio-Rad Laboratories

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Assure Tech

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Guangzhou Wondfo Biotech Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Wuhan Easy Diagnosis

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Getein Biotech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Beijing Hotgen Biotech Co.,ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Shanghai Upper Bio-Tech Pharma Co.,Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Qingdao Hightop Biotech Co.,Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Goldsite Diagnostics Inc.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Genrui Biotech Inc

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Hipro Biotechnology CO.,LTD

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Point-of-care Testing (POCT) for Inflammatory Market

Figure 4: Global Point-of-care Testing (POCT) for Inflammatory Market: Drivers

Figure 5: Global Point-of-care Testing (POCT) for Inflammatory Market: Challenges

Figure 6: Global Point-of-care Testing (POCT) for Inflammatory Market: Trends

Figure 7: Global Point-of-care Testing (POCT) for Inflammatory Market: Opportunity

Figure 8: Global Point-of-care Testing (POCT) for Inflammatory Market: Restraint

Figure 9: Global Point-of-care Testing (POCT) for Inflammatory Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Point-of-care Testing (POCT) for Inflammatory Market Value (USD Million) By Region

Figure 15: Global Point-of-care Testing (POCT) for Inflammatory Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Point-of-care Testing (POCT) for Inflammatory Market Value (USD Million) By Region

Figure 23: Global Point-of-care Testing (POCT) for Inflammatory Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Point-of-care Testing (POCT) for Inflammatory Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Point-of-care Testing (POCT) for Inflammatory Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Point-of-care Testing (POCT) for Inflammatory Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Point-of-care Testing (POCT) for Inflammatory Market Value (USD Million) By Region

Table 10: Global Point-of-care Testing (POCT) for Inflammatory Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Point-of-care Testing (POCT) for Inflammatory Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Point-of-care Testing (POCT) for Inflammatory Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Point-of-care Testing (POCT) for Inflammatory Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Roche Basic Information And Sales Area

Table 31: Roche. Products Portfolio

Table 32: Abbott Basic Information And Sales Area

Table 33: Abbott. Products Portfolio

Table 34: Siemens Healthineers Basic Information And Sales Area

Table 35: Siemens Healthineers. Products Portfolio

Table 36: BioMerieux Basic Information And Sales Area

Table 37: BioMerieux. Products Portfolio

Table 38: Bio-Rad Laboratories Basic Information And Sales Area

Table 39: Bio-Rad Laboratories. Products Portfolio

Table 40: Assure Tech Basic Information And Sales Area

Table 41: Assure Tech. Products Portfolio

Table 42: Guangzhou Wondfo Biotech Co.,Ltd. Basic Information And Sales Area

Table 43: Guangzhou Wondfo Biotech Co.,Ltd.. Products Portfolio

Table 44: Wuhan Easy Diagnosis Basic Information And Sales Area

Table 45: Wuhan Easy Diagnosis. Products Portfolio

Table 46: Getein Biotech Basic Information And Sales Area

Table 47: Getein Biotech. Products Portfolio

Table 48: Beijing Hotgen Biotech Co.,ltd. Basic Information And Sales Area

Table 49: Beijing Hotgen Biotech Co.,ltd.. Products Portfolio

Table 50: Shanghai Upper Bio-Tech Pharma Co.,Ltd. Basic Information And Sales Area

Table 51: Shanghai Upper Bio-Tech Pharma Co.,Ltd.. Products Portfolio

Table 52: Qingdao Hightop Biotech Co.,Ltd. Basic Information And Sales Area

Table 53: Qingdao Hightop Biotech Co.,Ltd.. Products Portfolio

Table 54: Goldsite Diagnostics Inc. Basic Information And Sales Area

Table 55: Goldsite Diagnostics Inc.. Products Portfolio

Table 56: Genrui Biotech Inc Basic Information And Sales Area

Table 57: Genrui Biotech Inc. Products Portfolio

Table 58: Hipro Biotechnology CO.,LTD Basic Information And Sales Area

Table 59: Hipro Biotechnology CO.,LTD. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Point-of-care Testing (POCT) for Inflammatory Market Value (USD Million) By Region

Table 65: Global Point-of-care Testing (POCT) for Inflammatory Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Point-of-care Testing (POCT) for Inflammatory Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.90 million
Revenue forecast in 2033	19.36 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Abbott; Siemens Healthineers; BioMerieux; Bio-Rad Laboratories; Assure Tech; Guangzhou Wondfo Biotech Co.,Ltd.; Wuhan Easy Diagnosis; Getein Biotech; Beijing Hotgen Biotech Co.,ltd.; Shanghai Upper Bio-Tech Pharma Co.,Ltd.; Qingdao Hightop Biotech Co.,Ltd.; Goldsite Diagnostics Inc.; Genrui Biotech Inc; Hipro Biotechnology CO.,LTD
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options